Jun 22–25, 2026 | Fairmont Chateau Whistler, Whistler, BC, Canada
Scientific Organizers:
Julia TCW, Christian Haass, and Emma Mead
-
Scientific Organizers: Julia TCW, Christian Haass, and Emma Mead
Julia TCW, PhD
Boston University
Christian Haass, PhD
Ludwig-Maximilians University Munich
Emma Mead, PhD
Oxford Drug Discovery Institute
Important Deadlines
Meeting Summary
Neurodegenerative disorders have devastating health impacts that increase disability and mortality in the human population. Despite decades of research, therapeutic approaches for treating neurodegenerative diseases have had limited success in the clinic. Neurodegenerative diseases share many overarching disease mechanisms, which include deposition of insoluble prion-like proteins but also strong non-neuronal contributions such as vascular and peripheral modifiers of disease progression and neuro-immunological risk factors. This Keystone Symposia conference on Neurodegeneration: From Neurocentric to System-Wide Perspectives focuses on the idea that a system-wide perspective on neurodegeneration, which includes all non-neuronal brain cells and influences from peripheral organs, will be essential for understanding neurodegenerative diseases and identifying new diagnostic biomarkers and potential disease-related targets for therapeutic intervention. The conference will therefore cover a broad spectrum of neurodegenerative disorders and include targeted sessions to discuss system-wide mechanistic research and the exciting possibility to identify unexpected therapeutic targets that may span diseases. The conference program includes a broad coverage of neurodegenerative disorders and strives to connect system-wide mechanistic insights that may identify common principles of neurodegenerative disease biology and identify new pathways for surveillance. This conference will be held jointly with a related Keystone Symposia conference on Neuroinflammation in Health and Disease, which provides a unique opportunity to focus on the intersection of neurodegenerative disease and inflammation pathways. Through shared keynote and joint scientific sessions, meals and poster sessions, participants will have an opportunity to network and share cross-disciplinary insights, encouraging innovative collaborations towards a deeper understanding of neurodegenerative disease and neuroimmune interactions, and the pathways that interconnect them.
In the video below, Dr. Julia TCW from Boston University, talks about what to expect from the meeting and why you should attend:
Also, check out the speaker highlights:
Unique Career Development Opportunities
This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives
SPECIAL RECOGNITION:
KEYSTONE SYMPOSIA THANKS THESE DONOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
THESE COMPANIES HAVE GENEROUSLY AGREED TO COVER THE EXPENSES OF THEIR EMPLOYEES WHO ARE SPEAKING AT THIS MEETING:
GRANT RECOGNITION:
Federal Funding provided by the National Institutes of Health:
Funding for this conference was made possible (in part) by 1R13NS149649-01 from NINDS. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of NIH; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
To access the NIH Safe Environment Policy, please click here.
KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS
Subscribe for Updates


